Skip to content
BLACK BOOK
manufacturer✓ Verified☎ Contact on file

BioXcel Therapeutics, Inc.

Pharmaceutical Preparations · New Haven, CT, United States

  1. PrincipalsFrank YoccaChief Scientific OfficerRichard I SteinhartChief Financial OfficerVimal MehtaCEO and Presidentand 8 more
  2. CompanyBioXcel Therapeutics, Inc.New Haven, CT, United States
  3. Phone line+1 (203) 643-8060General business
Request a quote

BioXcel Therapeutics, Inc. is an SEC-registered OTC-listed company (ticker BTAIQ) classified under SIC 2834: Pharmaceutical Preparations.

Capabilities

✓ Pharmaceutical manufacturing
Evidence for each capability
  • Pharmaceutical manufacturing. SIC 2834 — Pharmaceutical Preparations — SEC EDGAR company submissions

People 11

Chief executive

Vimal MehtaCEO and President

Chair & board

David J. MackDirector (Board)
June BrayDirector (Board)
Michael Patrick MillerDirector (Board)
Michal VotrubaDirector (Board)

Finance

Richard I SteinhartChief Financial Officer
Everyone else on file (2)
Frank YoccaChief Scientific Officer
Javier RodriguezOfficer (see SEC filing)

Supplier profile

Production
Yes

Source timeline

  1. Record created from SEC EDGAR company submissions

    SEC EDGAR company submissions ↗
  2. Frank Yocca — Chief Scientific Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  3. Richard I Steinhart — Chief Financial Officer

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗
  4. Javier Rodriguez — Officer (see SEC filing)

    SEC Insider Transactions Data Sets (Forms 3/4/5) ↗

Similar makers